Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, today announced that the Company has engaged Huntsworth Health, a global healthcare marketing and communications agency to build a global KOL advocacy campaign for CBMG's ReJoinTM human adipose-derived mesenchymal progenitor cell clinical trials for the treatment of Knee Osteoarthritis.
http://ift.tt/1D7ey1N
No comments:
Post a Comment